2006
DOI: 10.1016/j.peptides.2005.01.032
|View full text |Cite
|
Sign up to set email alerts
|

Structure–activity studies of new melanocortin peptides containing an aromatic amino acid at the N-terminal position

Abstract: Cyclic melanotropin peptides, designed with an aromatic amino acid substitution at the N-terminal position of the MT-II-type scaffold, were prepared by solid-phase peptide synthesis and evaluated for their ability to bind to and activate human melanocortin-1, -3, -4, and -5 receptors. The structureactivity studies of these MT-II analogues have identified a selective antagonist at the hMC4R

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

2
10
0

Year Published

2006
2006
2022
2022

Publication Types

Select...
8

Relationship

4
4

Authors

Journals

citations
Cited by 11 publications
(12 citation statements)
references
References 41 publications
2
10
0
Order By: Relevance
“…It is noteworthy that protein hot-spots relevant as therapeutic targets are frequently localized in Trp-rich β -hairpin regions [ 21 ]. Residues of Trp in the AA sequence of small bioactive peptides, as endogenous anti-inflammatory/antiobesity melanocortin peptides or defense antimicrobial peptides of innate immunity [ 22 , 23 ], need to be further explored in the field of peptides' structure-activity relationships.…”
Section: Tryptophan Residues In Proteins and Peptidesmentioning
confidence: 99%
“…It is noteworthy that protein hot-spots relevant as therapeutic targets are frequently localized in Trp-rich β -hairpin regions [ 21 ]. Residues of Trp in the AA sequence of small bioactive peptides, as endogenous anti-inflammatory/antiobesity melanocortin peptides or defense antimicrobial peptides of innate immunity [ 22 , 23 ], need to be further explored in the field of peptides' structure-activity relationships.…”
Section: Tryptophan Residues In Proteins and Peptidesmentioning
confidence: 99%
“…Previous reports from our laboratories (23–28) had focused on finding potent and selective agonists and antagonists for the hMC3R and hMC4R, which have been implicated to play complementary roles in weight control (11–17). Recently, Kavarana et al.…”
mentioning
confidence: 99%
“…In the meantime, B. Kest and colleagues (Juni et al, 2010) have shown that this ligand can modulate hyperalgesia in a gender specific manner. An analogue of Ac-Nle 4 -c[Asp 5 ,D-Phe 7 ,Lys 10 ]-α-MSH(4-10)-NH 2 in which the Nle 4 residue is replaced by a D-Phe and the His 6 residue by a Pro residue ( 3 , Table 1) (Grieco et al, 2006) gave a ligand that was more selective as an human melanocortin MC 3 receptor agonist than [D-Trp 8 ] γ-melanocyte stimulating hormone (Grieco et al, 2000) since it had antagonist activities at both the human melanocortin MC 4 receptor and human melanocortin MC 5 receptor. A very interesting and unique conformationally and topographically constrained analogue 4 (Table 1) was examined for its biological activity profile.…”
Section: Resultsmentioning
confidence: 99%